Lacrimal Cannulae Market Scope
Lacrimal cannula refers to a medical device used for probing and irrigation of the lacrimal duct. The lacrimal cannula market has high growth prospects owing to the increasing number of patients with ophthalmic disorders. Further, growing healthcare infrastructure in the developing economies and technological advancement in the healthcare industry propelling market growth. In addition, increasing eye surgeries expected to drive the demand for lacrimal cannula over the forecasted period.
Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Lacrimal Cannulae market throughout the predicted period.
B.Braun (Germany), Conmed (United States), Medtronic (Ireland), Medical Depot, Inc. (United States), Cook Medical (United States), Acutronic Medical (Switzerland), Asid Bonz (Germany), Bicakcilar (Turkey), Flexicare Medical (United Kingdom), Hager Werken (Germany) and Prince Medical (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Smith’s Group (United Kingdom), Stryker Corporation (United States) and Galemed (Taiwan).
Segmentation Overview
The study have segmented the market of Global Lacrimal Cannulae market by Type (Straight Lacrimal Cannulae and Curved Lacrimal Cannulae) and Region with country level break-up.
On the basis of geography, the market of Lacrimal Cannulae has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Influencing Trend:
Rising Demand from the Hospitals and Technological Advancement in the Healthcare Industry
Market Growth Drivers:
Growing Geriatric Population and Increasing Number of Eye Surgeries
Challenges:
Lack of Awareness in the Low and Middle Income Group Countries
Restraints:
Stringent Government Regulations Regarding Medical Devices and Lack of Medical Professional
Opportunities:
Rising Prevalence of Ophthalmic Disorders and Growing Healthcare Infratstrure in the Developing Economies
Market Leaders and their Expansionary Development Strategies
In September 2022,B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced today it has acquired the innovative Clik-FIX catheter securement device portfolio from Starboard Medical, Inc. B. Braun’s acquisition builds on the company’s history of product and program innovation to improve the patient experience and outcomes with peripheral intravenous (IV) therapy
In July, 2022 B. Braun Medical Inc. (B. Braun), a leader in infusion therapy, announced today the launch of its new Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun for making IV access safer for the clinician by reducing the risk of needlestick injuries and their exposure to blood.
Key Target Audience
Lacrimal Cannulae Manufacturers, Lacrimal Cannulae Distributors, Government Agencies, Commercial Research & Development Institutions, Government Organizations, Research Organizations, and Consulting Firms, Trade Associations and Industry Bodies and Others
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.